Euro Neurology 2020

• The Euro Neurology and Neurosurgery Congress is the leading conference for neurology and neurosurgeons in Europe.
• Euro Neurology 2020 targets neurologists, neurosurgeons, neuroscientists, neuroradiologists, neuro-oncologists, students, researchers, scholars, professors, business partners and other professionals in the field.
• The conference will be held in Paris this March 26-27, 2020.
• The conference features the foremost thought leaders and experts in the fields as keynote speakers.
• The neurology thought leaders outlined below are the primary speakers in the Euro Neurology 2020 conference.

Stefan Schwab

• Stefan Schwab is Professor of Neurology as well as Director and Chair of the Department of Neurology at Friedrich-Alexander University Erlangen-Nuremberg in Germany.
• He is also President of the European Stroke Research Network for Hypothermia (EuroHYP), German Neurocritical Care Society, and a founding member of the American Neurocritical Care Society.
• He has received numerous national and international awards for his groundbreaking research on stroke.
• Professor Schwab has written and co-authored over 200 publications on neurological and cerebrovascular diseases in scientific journals including Stroke, the European Journal of Neurology, Experimental Neurology and others.
• Professor Schwab's main research interests include stroke diagnostics, MRI, cerebral ischaemia, brain lesions, neuroprotection and pharmacokinetics among others.
• His recent work in the past 2 years was focused on advancing understanding and treatment of ischemic stroke.
• In April 2019, he co-authored the study "Therapeutic Hypothermia for Acute Ischaemic Stroke" published in the European Stroke Journal.
• He also co-authored the paper "Heart Failure in Ischemic Stroke" and its relevance for acute care published in the American Heart Association journal last September 2019.
• Professor Schwab recently co-authored the results of a 120-case study of idarucizumab in treatment of ischemic stroke published in the International Journal of Stroke this January 2020.

Jacques De Reuck

• Jacques De Reuck is Professor on Degenerative and Vascular Cognitive Disorders at the Université de Lille 2 in France.
• Professor De Reuck is current chairman and past President of the Congress Programme Committee of the European Federation of Neurological Societies (EFNS).
• He is also a founding member of the European Task Force on Age-Related White Matter Changes.
• He is a principal investigator in the Stroke and Atrial Fibrillation Ensemble (SAFE) II study as well as the Piracetam Acute Stroctorke Study (PASS).
• Professor De Reuck's research interests include stroke management and treatment, epilepsy and Parkinson's disease among others.
• Professor De Reuck has written over 500 peer-reviewed publications.
• His recent work in the past 2 years was focused on aging.
• He is the primary author of the paper " Aging And Cerebrovascular Lesion In Pure And In Mixed Neurodegenerative And Vascular Dementia Brains" published in Neuropathologica in 2018.
• Professor De Reuck has also published the study "Iron Deposition in the Brain during the Aging Process and in Neurodegenerative Diseases" in ECronicon last December 2019.
• Professor De Reuck has also spoken about brain lesions in the recent Neurovascular and Neurodegenerative Diseases international conference last October 2019.

Kurt A Jellinger

• Kurt Jellinger is Professor and Director of the Institute of Clinical Neurobiology as well as Professor of Neurology and Neuropathology at the Medical University in Austria.
• He has also served as the past Director of the Department of Neurology at Lainz Hospital in Vienna as well as the Ludwig Boltzmann Institute of Clinical Neurobiology.
• He has published over 1,000 papers in peer-reviewed journals, contributed to 170 scientific books, and gave 1,300 lectures at international meetings and conferences.
• Professor Jellinger has received numerous grants and awards for his work and served as editor of several journals covering neurology, neuroscience and neuropathology.
• Professor Jellinger's recent work in the past 2 years was focused on advancing understanding and treatment of neurodegenerative diseases.
• He has authored the paper "Proteomics For Synaptic Markers Of Cognitive Decline In Neurodegenerative Diseases" published in BRAIN on January 2018.
• He has also written "Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy" for the Journal of Alzheimers Disease's 20th anniversary issue on March 2018.
• Professor Jellinger has also spoken at the previous Brain Disorders and Therapeutics International Conference.

European Neurology

•  European Neurology is a journal from Karger Publishers, which is headquartered in Basel, Switzerland, that covers "clinical aspects of diseases of the nervous system and muscles, as well as their neuropathological, biochemical, and electrophysiological basis."
• It discusses and evaluates new treatments from "clinical evidence and basic investigative studies."
• In addition, there are also original articles on the history of neurology featured in this journal.
• Some of the top articles from the most recent volume include "How We Treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin Therapy," "Post-Thalamic Stroke Movement Disorders: A Systematic Review," and "MRI of Cerebellar Infarction."

Case Reports in Neurology

•  Case Reports in Neurology is a new peer-reviewed online only journal published by Karger, which is headquartered in Basel, Switzerland.
• The journal features "original case reports covering the entire spectrum of neurology."
•  Case Reports in Neurology focuses mostly on research findings.
• Current top articles in this journal include "Sneddon Syndrome: A Case Report Exploring the Current Challenges Faced with Diagnosis and Management," "Convulsive Seizures as Presenting Symptom of Metronidazole-Induced Encephalopathy: A Case Report," and "Acute Intermittent Porphyria: A Report of 3 Cases with Neuropathy."

European Medical Journal Neurology

• EMJ Neurology is a journal published by EMJ, an "independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in medicine."
• EMJ is headquartered in London, England.
• The journal focuses on topics related to research, treatments, opportunities, and events.
• Recent articles that have appeared in the EMJ Neurology journal include "Improving intravenous immunoglobulin dosing in autoimmune neuropathies," "Optimism and opportunities with anti-CGRP biologics in migraine: where are we today?," and "Classification of Pontocerebellar Hypoplasia: Where does it end?"

Insights in Neurosurgery

•  Insights in Neurosurgery is an open access journal based in London, England that covers all aspects of neurology.
• Physicians can exchange ideas on the platform to allow for the "advancement of science and the art of surgery."
• Specifically, the journal focuses on instrumentation, technology, patient management, complications, research, advancements, and treatments of "neurosurgical focuses, traumatic brain and spinal cord injury."
• Recent articles in this journal include "Capsule Granulation Tissue Harvested From Abdominal Region Used as Dural Autologous Graft" and "Using Eggshell Membrane in the Fresh Cadaveric Cow Brain for Brain Protection."

34th European Neurology Congress

• The 34th European Neurology Congress is scheduled for June 24-25, 2020, in Zurich, Switzerland.
• World class experts in the fields of neurology and neuroscience gather together to discuss topics related to "Clinical Neurophysiology, Neurosurgery, Neuro Muscular Disorders, Neuro Infectious Diseases, Pediatric Neurology, Neuropathology, Brain Tumor and Neuro-oncology, and many more."
• The focus of this congress is to identify genetic pathways that underlay neurological disorders as "tools to develop therapeutics."
• There are 19 tracks at the congress, which are neurology, clinical neurophysiology, neurosurgery, central nervous system, pediatric neurology, neuromuscular disorders, psychiatry and psychology, spine and spinal disorders, neurogenetic and neurometabolic disorders, neuropharmacology, nursing and neuroscience, neuroimmunology and neuroinfections, brain tumor and neuro-oncology, neuroplasticity & neurorehabilitation, neuropathology, neuro cardiology & strokes, critical care neurology, neurology education, and clinical trials & case reports.

European Academy of Neurology Congress

• The European Academy of Neurology Congress is scheduled for May 23-26, 2020, in Paris, France.
• The mission of the European Academy of Neurology is to "promote neurological excellence in Europe and across the world, leading to better patient care and outcomes."
• The types of subjects covered include research, new technologies, treatments, and challenges facing neurologists.
• Topics covered at the European Academy of Neurology Congress include "Can we protect and repair the brain after stroke," "Molecular mechanisms for the treatment of hereditary CNS disorders," and "Understanding apraxia."

Dementias 2020

• Dementias 2020 is scheduled for February 13-14, 2020 in London, England.
• This event focuses on treatment, management, and prevention of dementia.
•  Topics that will be covered in sessions include "Use of imaging in Dementia," "Head injury and dementias," and "New therapeutic approaches for Alzheimer’s disease and other dementias."